Monday, June 27, 2022

Brain Stimulation May Reduce Negative Symptoms of Schizophrenia, Meta-Analysis Suggests

Noninvasive neuromodulation therapies that excite neurons in a specific part of the brain’s prefrontal cortex are effective at reducing negative symptoms of schizophrenia such as social withdrawal or lack of communication, according to a meta-analysis in JAMA Psychiatry. The analysis found that both magnetic stimulation and electrical stimulation approaches can be effective.

“Although antipsychotic drugs are relatively effective in mitigating positive symptoms of schizophrenia, their efficacy is limited for the treatment of the negative symptoms of the illness,” wrote Ping-Tao Tseng, M.D., Ph.D., of Asia University in Taichung, Taiwan.

The researchers compiled data from 48 randomized clinical trials comparing the effects of active brain stimulation versus a sham control in patients with schizophrenia or schizoaffective disorder. The combined data included 2,211 participants and 22 neuromodulation techniques, including repetitive transcranial magnetic stimulation (rTMS) and transcranial direct current stimulation (tDCS).

The meta-analysis revealed seven neuromodulation therapies that led to greater improvements in negative symptoms compared with sham stimulation. These included high-definition transcranial random noise stimulation (which involves stimulating the brain with electrical currents that continually change frequency), high frequency (10 Hz) and extreme high frequency (20 Hz) rTMS, intermittent theta burst stimulation (TMS that is applied in very rapid bursts), and three slight variations of tDCS. All seven approaches involved high-frequency stimulation to a region in the dorsolateral prefrontal cortex called F3.

High-definition transcranial random noise stimulation was associated with the greatest alleviation of negative symptoms. The analysis also revealed that patients who received combined tDCS stimulation to both F3 and another cortical region called F4 experienced significant improvements in both negative symptoms and depressive symptom severity compared with patients who received sham stimulation. Tseng and colleagues cautioned both these results came from just one study each.

“To our knowledge, this is the first network meta-analysis to directly investigate the potential benefits of [noninvasive brain stimulation] for treating negative symptom severity in patients with schizophrenia,” Tseng and colleagues wrote. “Our findings might serve as a starting point for future large-scale RCTs with longer follow-up periods and sham control to investigate the association between [noninvasive brain stimulation] and negative symptoms in schizophrenia.”

For related information, see the American Journal of Psychiatry article “Cerebellar-Prefrontal Network Connectivity and Negative Symptoms in Schizophrenia.”

(Image: iStock/Hank Grebe)




Don't miss out! To learn about newly posted articles in Psychiatric News, please sign up here.


Disclaimer

The content of Psychiatric News does not necessarily reflect the views of APA or the editors. Unless so stated, neither Psychiatric News nor APA guarantees, warrants, or endorses information or advertising in this newspaper. Clinical opinions are not peer reviewed and thus should be independently verified.